Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.
Identifieur interne : 001180 ( Main/Exploration ); précédent : 001179; suivant : 001181Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.
Auteurs : Morteza Abdullatif Khafaie [Iran] ; Fakher Rahim [Iran]Source :
- Osong public health and research perspectives [ 2210-9099 ] ; 2020.
Abstract
Objectives
Case fatality rates (CFR) and recovery rates are important readouts during epidemics and pandemics. In this article, an international analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic.
Methods
Data were retrieved from accurate databases according to the user's guide of data sources for patient registries, CFR and recovery rates were calculated for each country. A comparison of CFR between countries with total cases ≥ 1,000 was observed for 12
Results
Italy's CFR was the highest of all countries studied for both time points (12
Conclusion
Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease.
DOI: 10.24171/j.phrp.2020.11.2.03
PubMed: 32257772
PubMed Central: PMC7104689
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.</title><author><name sortKey="Khafaie, Morteza Abdullatif" sort="Khafaie, Morteza Abdullatif" uniqKey="Khafaie M" first="Morteza Abdullatif" last="Khafaie">Morteza Abdullatif Khafaie</name><affiliation wicri:level="1"><nlm:affiliation>Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz</wicri:regionArea><wicri:noRegion>Ahvaz</wicri:noRegion></affiliation></author><author><name sortKey="Rahim, Fakher" sort="Rahim, Fakher" uniqKey="Rahim F" first="Fakher" last="Rahim">Fakher Rahim</name><affiliation wicri:level="1"><nlm:affiliation>Health Research Institute, Research Center of Thalassemia and Hemoglobinopathies, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Health Research Institute, Research Center of Thalassemia and Hemoglobinopathies, Ahvaz Jundishapur University of Medical Sciences, Ahvaz</wicri:regionArea><wicri:noRegion>Ahvaz</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32257772</idno><idno type="pmid">32257772</idno><idno type="doi">10.24171/j.phrp.2020.11.2.03</idno><idno type="pmc">PMC7104689</idno><idno type="wicri:Area/Main/Corpus">001782</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001782</idno><idno type="wicri:Area/Main/Curation">001782</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001782</idno><idno type="wicri:Area/Main/Exploration">001782</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.</title><author><name sortKey="Khafaie, Morteza Abdullatif" sort="Khafaie, Morteza Abdullatif" uniqKey="Khafaie M" first="Morteza Abdullatif" last="Khafaie">Morteza Abdullatif Khafaie</name><affiliation wicri:level="1"><nlm:affiliation>Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz</wicri:regionArea><wicri:noRegion>Ahvaz</wicri:noRegion></affiliation></author><author><name sortKey="Rahim, Fakher" sort="Rahim, Fakher" uniqKey="Rahim F" first="Fakher" last="Rahim">Fakher Rahim</name><affiliation wicri:level="1"><nlm:affiliation>Health Research Institute, Research Center of Thalassemia and Hemoglobinopathies, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Health Research Institute, Research Center of Thalassemia and Hemoglobinopathies, Ahvaz Jundishapur University of Medical Sciences, Ahvaz</wicri:regionArea><wicri:noRegion>Ahvaz</wicri:noRegion></affiliation></author></analytic><series><title level="j">Osong public health and research perspectives</title><idno type="ISSN">2210-9099</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>Objectives</b></p><p>Case fatality rates (CFR) and recovery rates are important readouts during epidemics and pandemics. In this article, an international analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic.</p></div><div type="abstract" xml:lang="en"><p><b>Methods</b></p><p>Data were retrieved from accurate databases according to the user's guide of data sources for patient registries, CFR and recovery rates were calculated for each country. A comparison of CFR between countries with total cases ≥ 1,000 was observed for 12</p></div><div type="abstract" xml:lang="en"><p><b>Results</b></p><p>Italy's CFR was the highest of all countries studied for both time points (12</p></div><div type="abstract" xml:lang="en"><p><b>Conclusion</b></p><p>Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease.</p></div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32257772</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2210-9099</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Osong public health and research perspectives</Title><ISOAbbreviation>Osong Public Health Res Perspect</ISOAbbreviation></Journal><ArticleTitle>Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.</ArticleTitle><Pagination><MedlinePgn>74-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24171/j.phrp.2020.11.2.03</ELocationID><Abstract><AbstractText Label="Objectives" NlmCategory="UNASSIGNED">Case fatality rates (CFR) and recovery rates are important readouts during epidemics and pandemics. In this article, an international analysis was performed on the ongoing coronavirus disease 2019 (COVID-19) pandemic.</AbstractText><AbstractText Label="Methods" NlmCategory="UNASSIGNED">Data were retrieved from accurate databases according to the user's guide of data sources for patient registries, CFR and recovery rates were calculated for each country. A comparison of CFR between countries with total cases ≥ 1,000 was observed for 12<sup>th</sup> and 23<sup>rd</sup> March.</AbstractText><AbstractText Label="Results" NlmCategory="UNASSIGNED">Italy's CFR was the highest of all countries studied for both time points (12<sup>th</sup> March, 6.22% versus 23<sup>rd</sup> March, 9.26%). The data showed that even though Italy was the only European country reported on 12<sup>rd</sup> March, Spain and France had the highest CFR of 6.16 and 4.21%, respectively, on 23<sup>rd</sup> March, which was strikingly higher than the overall CFR of 3.61%.</AbstractText><AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Obtaining detailed and accurate medical history from COVID-19 patients, and analyzing CFR alongside the recovery rate, may enable the identification of the highest risk areas so that efficient medical care may be provided. This may lead to the development of point-of-care tools to help clinicians in stratifying patients based on possible requirements in the level of care, to increase the probabilities of survival from COVID-19 disease.</AbstractText><CopyrightInformation>Copyright ©2020, Korea Centers for Disease Control and Prevention.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khafaie</LastName><ForeName>Morteza Abdullatif</ForeName><Initials>MA</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-1651-3017</Identifier><AffiliationInfo><Affiliation>Social Determinants of Health Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahim</LastName><ForeName>Fakher</ForeName><Initials>F</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-2857-4562</Identifier><AffiliationInfo><Affiliation>Health Research Institute, Research Center of Thalassemia and Hemoglobinopathies, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Osong Public Health Res Perspect</MedlineTA><NlmUniqueID>101563309</NlmUniqueID><ISSNLinking>2210-9099</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">case fatality rates</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword></KeywordList><CoiStatement>Conflicts of Interest The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32257772</ArticleId><ArticleId IdType="doi">10.24171/j.phrp.2020.11.2.03</ArticleId><ArticleId IdType="pii">ophrp-11-74</ArticleId><ArticleId IdType="pmc">PMC7104689</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Feb 28;69(8):216-219</Citation><ArticleIdList><ArticleId IdType="pubmed">32106216</ArticleId></ArticleIdList></Reference><Reference><Citation>AJR Am J Roentgenol. 2020 Mar 3;:1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">32125873</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Sci Pollut Res Int. 2018 Jun;25(16):15918-15924</Citation><ArticleIdList><ArticleId IdType="pubmed">29589237</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Feb 19;368:m606</Citation><ArticleIdList><ArticleId IdType="pubmed">32075786</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Pulmonol. 2020 Mar 5;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32134205</ArticleId></ArticleIdList></Reference><Reference><Citation>Biometrics. 2012 Jun;68(2):598-606</Citation><ArticleIdList><ArticleId IdType="pubmed">22276951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Feb 27;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32104917</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Mar 28;395(10229):1035-1036</Citation><ArticleIdList><ArticleId IdType="pubmed">32199073</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 May;92(5):479-490</Citation><ArticleIdList><ArticleId IdType="pubmed">32052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2020 Feb;25(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">32019636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 Mar 10;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation><ArticleIdList><ArticleId IdType="pubmed">31986257</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Feb 28;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Yi Xue Za Zhi. 2020 Mar 08;100(0):E017</Citation><ArticleIdList><ArticleId IdType="pubmed">32145717</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Med. 2020 Feb 26;9(3):</Citation><ArticleIdList><ArticleId IdType="pubmed">32110875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Khafaie, Morteza Abdullatif" sort="Khafaie, Morteza Abdullatif" uniqKey="Khafaie M" first="Morteza Abdullatif" last="Khafaie">Morteza Abdullatif Khafaie</name></noRegion><name sortKey="Rahim, Fakher" sort="Rahim, Fakher" uniqKey="Rahim F" first="Fakher" last="Rahim">Fakher Rahim</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001180 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001180 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32257772
|texte= Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32257772" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |